Wan et al. [26] demonstrated that CSN5 (a deubiquitination enzyme in the JAMM family) boosted EGFR stability by decreasing EGFR ubiquitination level, activating the EGFR/PI3K/AKT signaling pathway to promote multiple features of osteosarcoma pathogenesis. This evidence concerns the gene EGFR and osteosarcoma.